INtRON Biotechnology (Korea) Price Prediction
| 048530 Stock | KRW 5,690 190.00 3.45% |
Oversold Vs Overbought
54
Oversold | Overbought |
Using INtRON Biotechnology hype-based prediction, you can estimate the value of iNtRON Biotechnology from the perspective of INtRON Biotechnology response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in INtRON Biotechnology to buy its stock at a price that has no basis in reality. In that case, they are not buying INtRON because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
INtRON Biotechnology after-hype prediction price | KRW 5690.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
INtRON |
INtRON Biotechnology After-Hype Price Prediction Density Analysis
As far as predicting the price of INtRON Biotechnology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in INtRON Biotechnology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of INtRON Biotechnology, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
INtRON Biotechnology Estimiated After-Hype Price Volatility
In the context of predicting INtRON Biotechnology's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on INtRON Biotechnology's historical news coverage. INtRON Biotechnology's after-hype downside and upside margins for the prediction period are 5,686 and 5,694, respectively. We have considered INtRON Biotechnology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
INtRON Biotechnology is very steady at this time. Analysis and calculation of next after-hype price of iNtRON Biotechnology is based on 3 months time horizon.
INtRON Biotechnology Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as INtRON Biotechnology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading INtRON Biotechnology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with INtRON Biotechnology, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.04 | 3.58 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
5,690 | 5,690 | 0.00 |
|
INtRON Biotechnology Hype Timeline
iNtRON Biotechnology is presently traded for 5,690on KOSDAQ of Korea. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. INtRON is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is presently at 0.04%. %. The volatility of related hype on INtRON Biotechnology is about 0.0%, with the expected price after the next announcement by competition of 5,690. About 16.0% of the company shares are owned by insiders or employees . The company has Price/Earnings (P/E) ratio of 313.17. iNtRON Biotechnology had not issued any dividends in recent years. The entity had 2:1 split on the 10th of January 2019. Assuming the 90 days trading horizon the next forecasted press release will be in 5 to 10 days. Check out INtRON Biotechnology Basic Forecasting Models to cross-verify your projections.INtRON Biotechnology Related Hype Analysis
Having access to credible news sources related to INtRON Biotechnology's direct competition is more important than ever and may enhance your ability to predict INtRON Biotechnology's future price movements. Getting to know how INtRON Biotechnology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how INtRON Biotechnology may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| 086900 | Medy Tox | 0.00 | 0 per month | 0.00 | (0.15) | 4.68 | (4.34) | 24.81 | |
| 039200 | Oscotec | 0.00 | 0 per month | 0.00 | (0.18) | 3.58 | (5.86) | 11.55 | |
| 095700 | Genexine | 0.00 | 0 per month | 0.00 | (0.33) | 4.07 | (5.62) | 11.08 | |
| 084990 | Helixmith Co | 0.00 | 0 per month | 0.00 | (0.23) | 3.97 | (4.77) | 13.56 |
INtRON Biotechnology Additional Predictive Modules
Most predictive techniques to examine INtRON price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for INtRON using various technical indicators. When you analyze INtRON charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About INtRON Biotechnology Predictive Indicators
The successful prediction of INtRON Biotechnology stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as iNtRON Biotechnology, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of INtRON Biotechnology based on analysis of INtRON Biotechnology hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to INtRON Biotechnology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to INtRON Biotechnology's related companies.
Story Coverage note for INtRON Biotechnology
The number of cover stories for INtRON Biotechnology depends on current market conditions and INtRON Biotechnology's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that INtRON Biotechnology is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about INtRON Biotechnology's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
INtRON Biotechnology Short Properties
INtRON Biotechnology's future price predictability will typically decrease when INtRON Biotechnology's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of iNtRON Biotechnology often depends not only on the future outlook of the potential INtRON Biotechnology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. INtRON Biotechnology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 33.7 M | |
| Cash And Short Term Investments | 83.5 B | |
| Shares Float | 26.7 M |
Complementary Tools for INtRON Stock analysis
When running INtRON Biotechnology's price analysis, check to measure INtRON Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy INtRON Biotechnology is operating at the current time. Most of INtRON Biotechnology's value examination focuses on studying past and present price action to predict the probability of INtRON Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move INtRON Biotechnology's price. Additionally, you may evaluate how the addition of INtRON Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |